Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00937924 · ClinicalTrials.gov registry record · Phase 4
Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures
A Phase 4 study of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS), sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 304
- Enrollment target
- 1
- Study location
NCT00937924: Completed Phase 4 study of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS), sponsored by University of California, Irvine.
NCT00937924 is a Phase 4 study of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS) that has completed, run by University of California, Irvine. The registered enrollment target is 304 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00937924, a Phase 4 study of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS), has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare meperidine/midazolam with diphenhydramine, meperidine/midazolam with promethazine, and meperidine/midazolam with placebo as sedation methods. The investigators are interested to see whether adjunct sedatives (diphenhydramine and promethazine) will improve sedation.
Primary Outcome
The percentage of participants who could not complete the procedure due inability to achieve proper sedation level
Conditions Studied
Interventions
- DRUG Diphenhydramine
- DRUG Promethazine
- DRUG Meperidine, Midazolam
Study Locations (1)
California
- H.H. Chao Comprehensive Digestive Disease Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
What the finished NCT00937924 record still lists
NCT00937924 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with Endoscopic Retrograde Cholangiopancreatography (ERCP) appearing as the primary indexed condition, and to 3 interventions - of which Diphenhydramine is the first listed.
NCT00937924 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00937924 about?
NCT00937924 is a clinical study titled "Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures". The purpose of this study is to compare meperidine/midazolam with diphenhydramine, meperidine/midazolam with promethazine, and meperidine/midazolam with placebo as sedation methods. The investigators are interested to see whether adjunct sedatives (diphenhydramine and promethazine) will improve seda...
What is the current status of trial NCT00937924?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 304 participants. The study started on 2008-02. Estimated completion is 2012-06.
What conditions does trial NCT00937924 study?
This clinical trial studies the following conditions: Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS).
What interventions are being tested in trial NCT00937924?
The interventions under investigation include: Diphenhydramine (DRUG), Promethazine (DRUG), Meperidine, Midazolam (DRUG).
Who is sponsoring clinical trial NCT00937924?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00937924 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00937924's enrollment target sits among peer trials
304 264th of 2000 higher than 1,735 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia